Two teams – quality control and quality assurance – work together with research teams to ensure that studies are conducted in compliance with Good Laboratory Practice (21 CFR, part 58 – GLP). Compliance with this standard is essential for consideration of submissions to the FDA.
At AccelLAB, quality control (QC) is a rigorous and continuous process of system, procedure, and data analysis, with the aim of ensuring continuous process improvement.
The QC team participates in preparation and execution of studies, and conducts prompt data verification to ensure adherence to current procedures and to provide feedback.
The management of the QA team consists of individuals holding RQAP-GLP (registered quality assurance professional – GLP) certification from the Society of Quality Assurance.
Studies are inspected at regular intervals beginning with the study protocol, continuing through the actual conduct of the study, and ending with the final report.
Open communication with the operations group is encouraged, which creates a team approach to the conduct of GLP studies. This philosophy facilitates the realization of the common goal shared by AccelLAB as a whole: a scientifically rigorous, fully compliant final report.